Can 18-FDG-PET during radiotherapy replace post-therapy scanning for detection/demonstration of tumor response in head-and-neck cancer?

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages 938-942

  Ceulemans, Gaëtane ^a   Voordeckers, Mia ^a   Farrag, Ashraf ^a   Verdries, Douwe ^a   Storme, Guy ^a   Everaert, Hendrik ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

early response assessment using FDG PET; FDG PET tumor response; fluorodeoxyglucose positron emission tomography; Head and neck cancer; IMRT; intensity modulated radiotherapy; response during RT

Indexed keywords

FDG-PET; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; HEAD-AND-NECK CANCER; IMRT; INTENSITY-MODULATED RADIOTHERAPY; RESPONSE DURING RT;

DISEASES; PHYSICAL THERAPY; POSITRONS; RADIOTHERAPY; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

CISPLATIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEAD AND NECK CANCER; HUMAN; IMAGE RECONSTRUCTION; MALE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE; SENSITIVITY AND SPECIFICITY; SMOKING; TOMOTHERAPY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY, INTENSITY-MODULATED; REMISSION INDUCTION; SURVIVAL RATE; TIME FACTORS; UNNECESSARY PROCEDURES;

EID: 80255134567     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.07.019     Document Type: Article

References (27)

1. C. Horiuchi, T. Taguchi, and T. Yoshida Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomotherapy Auris Nasus Larynx 35 2008 103 108
2. E. Brun, E. Kjellén, and J. Tennvall FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma Head Neck 24 2002 127 135 (Pubitemid 34111509)
3. G.B. Van Den broeck, M. Wildeman, and C.R. Rasch Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation Int J Cancer 124 2009 2643 2650
4. C.S. Kong, B. Narasimhan, and H. Cao The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 74 2009 553 561
5. H. Schröder, M. Fury, and N. Lee PET monitoring of therapy response in head and neck squamous cell carcinoma J Nucl Med 50 2009 74S 88S
6. H. Sakamoto, Y. Nakai, and Y. Ohashi Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas Acta Otolaryngol 538 Suppl. 1998 254 260 (Pubitemid 28563353)
7. K.M. Greven, D.W. Williams III, and W.F. McGuirt Sr. Serial positron emission tomography scans following radiation therapy in patients with head and neck cancer Head Neck 23 2001 942 946 (Pubitemid 32977536)
8. N.G. Mikhaeel, M. Hutchings, and P.A. Fields FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high grade non-Hodgkin lymphoma Ann Oncol 16 2005 1514 1523 (Pubitemid 41222425)
9. 18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC) Lung cancer 62 2008 55 61
10. 18F-fluorodeoxyglucose positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer Int J Radiat Oncol Biol Phys 72 2008 1502 1507
11. M. Schelling, N. Avril, and W. Nährig Positron emission tomography using 18F fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer J Clin Oncol 18 2000 1689 1695 (Pubitemid 30220547)
12. G.W. Goerres, D.T. Schmid, and F. Bandhauer Positron emission tomography in the early follow-up of advanced head and neck cancer Arch Otolaryngol Head Neck Surg 130 2004 105 109 (Pubitemid 38095439)
13. S.Y. Nam, S.W. Lee, and K.C. Im Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET Oral Oncol 41 2005 390 395 (Pubitemid 40387868)
14. K.M. Greven, D.W. Williams III, and J.W. Keyes Jr. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation Cancer 74 1994 1355 1359 (Pubitemid 24301792)
15. J.W. Rogers, K.W. Greven, and W.F. McGuirt Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 58 2004 694 697 (Pubitemid 38221123)
16. S. Kohlfürst, M. Markitz, and W. Raunik Positron-emission tomography (PET) and PET/computed tomography in head and neck cancer - Recommendations of an interdisciplinary consensus conference Laryngorhinootologie 88 2009 84 90
17. R.J. Wong Current status of FDG-PET for head and neck cancer J Surg Oncol 15 97 2008 649 652 (Pubitemid 351812964)
18. D. Verellen, N. Linthout, and G. Storme Target localization and treatment verification for intensity modulated conformal radiation therapy of the head and neck region: The AZ-VUB experience. Akademisch ziekenhuis Vrije Universiteit Brussel Strahlenther Onkol 174 Suppl. 2 1998 19 27 (Pubitemid 28475978)
19. C. Fiorino, I. Dell'Oca, and A. Pierelli Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy: A planning study Strahlenther Oncol 183 2007 497 505 (Pubitemid 47347930)
20. M. Voordeckers, H. Everaert, and K. Tournel Longitudinal assessment of parotid function in patients receiving tomotherapy for head and neck cancer Strahlenther Onkol 8 2008 400 405
21. V. Grégoire, E. Coche, and G. Cosnard Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy: Proposal for standardizing terminology and procedure based on the surgical experience Radiother Oncol 56 2000 135 150 (Pubitemid 30601670)
22. M.D. Goodman, M. Tarnoff, and M. Kain Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer: Southern New Jersey Head and Neck Cancer Treatment Group Am J Surg 174 1997 527 531 (Pubitemid 27486019)
23. G. Szabo, J. Kreidler, and K. Hollmann Intra-arterial preoperative cytostatic treatment versus preoperative irradiation: A prospective, randomized study of lingual and sublingual carcinomas Cancer 86 1999 1381 1386 (Pubitemid 29489768)
24. L. Kostakoglu, M. Coleman, and J.P. Leonard PET predicts prognosis after one cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease J Nucl Med 43 2002 1018 1027 (Pubitemid 34847924)
25. C. Haouin, R. Itti, and A. Rahmouni 18F fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: An early prognostic tool for predicting patient outcome Blood 106 2005 1376 1381 (Pubitemid 41129604)
26. E. Brun, E. Kjellen, and J. Tenvall FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma Head Neck 24 2002 127 135 (Pubitemid 34111509)
27. R.J. Wong, D.T. Lin, and H. Schroder Diagnostic and prognostic value of 18F fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma J Clin Oncol 20 2002 4199 4208 (Pubitemid 35191022)